Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

RNARNA
2 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ATRIUM THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 386,929 shares of RNA (ATRIUM THERAPEUTICS INC), worth $5.2M as of 2026-Q2. The position was increased (+21.0% shares). RNA represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$5.2M

Current Shares

386,929

Total Value Change

+$928,148

Total Shares Change

+67,098

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
386,929
+21.0%
$5.2M0.0%$13.45
32
2026-Q1
New
319,831
-
$4.3M0.0%$15.67
37

Other major holders of RNA: PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used